Subscribe to RSS

DOI: 10.1055/s-0045-1812300
Beyond the tumor: endocrine and metabolic dysregulation in intracranial germ cell tumors – a retrospective cohort study
Authors
Funding The authors declare that the present study was funded by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.
Abstract
Background
Intracranial germ cell tumors (iGCTs) often lead to endocrine-metabolic complications; however, their long-term effects are not well understood and characterized.
Objective
To evaluate endocrine-metabolic dysfunction before and after iGCTs treatment.
Methods
The present retrospective study included 99 patients with iGCTs treated at a tertiary hospital. Endocrine and metabolic parameters were assessed before and after treatment.
Results
A male sex predominance was observed (81.8%). The leading site was pineal (44.4%), and 67.7% of the tumors were classified as germinoma. Radiotherapy was performed in 82.8% of the cases (58.5% cranial and 41.5% craniospinal). At diagnosis, the incidences of gonadotropin-independent precocious puberty and diabetes insipidus were 15.2% and 48.2%, respectively. Significant endocrine-metabolic changes in patients with iGCTs were observed after treatment, as 72.3% of patients required hormone replacement, 60% had growth hormone deficiency, and dyslipidemia was observed in 49.2% of patients. Overweight increased from 24.2 to 35.4% after treatment, while obesity increased from 10.1 to 15.4%. There was an increase in growth hormone deficiency, hypothyroidism, and hypogonadism, while prolactin levels significantly decreased after treatment. An older age at diagnosis was associated with a lower risk of hypocortisolism (p = 0.005). Regarding sex, females had lower height Z-scores and a higher frequency of growth hormone deficiency compared with males. Tumor-related mortality was reported in 22.2% of patients, occurring on average 2.2 years postdiagnosis.
Conclusion
The high prevalence of endocrine-metabolic complications following radiotherapy highlights the necessity of ongoing monitoring. The treatment demonstrated significant efficacy, as reflected by the notable survival rates. Early intervention is crucial for improving the long-term quality of life.
Keywords
Germinoma - Central Nervous System Diseases - Hypopituitarism - Obesity - Diabetes Insipidus - RadiotherapyAuthors' Contributions
Conceptualization: MJRS, AMSC, NSS, AC, PMMO, ASSM; Data curation: MJRS, AMSC, PMMO, ASSM; Formal analysis: MJRS, AMSC, PMMO, ASSM; Funding acquisition: MJRS, AMSC, ASSM; Investigation: MJRS, AMSC, ASSM; Methodology: MJRS, AMSC, PMMO, ASSM; Project administration: MJRS, AMSC, ASSM; Resources: MJRS, AMSC, ASSM; Software: MJRS, AMSC, PMMO, ASSM; Supervision: MJRS, AMSC, NSS, AC, PMMO, ASSM; Validation: MJRS, AMSC, PMMO, ASSM; Visualization: MJRS, AMSC, PMMO, ASSM; Writing – original draft: MJRS, AMSC, NSS, AC, PMMO, ASSM; Writing – review & editing: MJRS, AMSC, NSS, AC, PMMO, ASSM.
Data Availability Statement
The datasets generated and analyzed during the current study are not publicly available due to ongoing manuscript submissions but are available from the corresponding author upon reasonable request. All relevant research materials, including the codebooks and analysis scripts, were prepared for sharing and distribution. The corresponding author will provide these materials through a secure, anonymized database.
Editor-in-Chief: Hélio A. G. Teive (0000-0003-2305-1073).
Associate Editor: Suzana Maria Fleury Malheiros (0000-0003-3433-6867).
Publication History
Received: 23 April 2025
Accepted: 02 August 2025
Article published online:
27 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Mayco José Reinaldi Serra, Angela Maria Spinola-Castro, Nasjla Saba da Silva, Andrea Cappellano, Paola Matiko Martins Okuda, Adriana Aparecida Siviero-Miachon. Beyond the tumor: endocrine and metabolic dysregulation in intracranial germ cell tumors – a retrospective cohort study. Arq Neuropsiquiatr 2025; 83: s00451812300.
DOI: 10.1055/s-0045-1812300
-
References
- 1 Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. Neuro-oncol 2021; 23 (12, Suppl 2) iii1-iii105
- 2 Wong TT, Ho DM, Chang KP, Yen SH, Guo WY, Chang FC. et al. Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer 2005; 104 (10) 2156-2167
- 3 Magalhães GA, Magalhães DMdA, Bellas GO, Figueiredo Junior I. Epidemiological, Clinical, and Pathological Analysis of Children with Central Nervous System Neoplasms Treated with Radiotherapy at the National Cancer Institute. Rev Bras Cancerol 2023; 69 (04) e–054051
- 4 Echevarría ME, Fangusaro J, Goldman S. Pediatric central nervous system germ cell tumors: a review. Oncologist 2008; 13 (06) 690-699
- 5 Weksberg DC, Shibamoto Y, Paulino AC. Bifocal intracranial germinoma: a retrospective analysis of treatment outcomes in 20 patients and review of the literature. Int J Radiat Oncol Biol Phys 2012; 82 (04) 1341-1351
- 6 Fujimaki T. Central nervous system germ cell tumors: classification, clinical features, and treatment with a historical overview. J Child Neurol 2009; 24 (11) 1439-1445
- 7 Kremenevski N, Buchfelder M, Hore N. Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management. Curr Oncol Rep 2023; 25 (07) 765-775
- 8 Tosta-Hernandez PDC, Siviero-Miachon AA, Silva NSd, Cappellano A, Pinheiro MM, Spinola-Castro AM. Childhood Craniopharyngioma: A 22-Year Challenging Follow-Up in a Single Center. Horm Metab Res 2018; 50 (09) 675-682
- 9 Silva NSd, Cappellano AM, Diez B, Cavalheiro S, Gardner S, Wisoff J. et al. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study. Pediatr Blood Cancer 2010; 54 (03) 377-383
- 10 Cappellano AM, Dassi N, Mançano B, Epelman S, Almeida DB, Cavalheiro S. et al. Outcome of Children and Adolescents With Primary Intracranial Germinoma Treated With Chemotherapy and Reduced Dose-Field Irradiation: A Prospective Brazilian Experience. JCO Glob Oncol 2023; 9: e2200257
- 11 WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl 2006; 450: 76-85
- 12 Onis Md, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007; 85 (09) 660-667
- 13 Elkins C, Fruh S, Jones L, Bydalek K. Clinical Practice Recommendations for Pediatric Dyslipidemia. J Pediatr Health Care 2019; 33 (04) 494-504
- 14 Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115 (04) e500-e503
- 15 Diniz MFHS, Beleigoli AMR, Schmidt MI, Duncan BB, Ribeiro ALP, Vidigal PG. et al. Homeostasis model assessment of insulin resistance (HOMA-IR) and metabolic syndrome at baseline of a multicentric Brazilian cohort: ELSA-Brasil study. Cad Saude Publica 2020; 36 (08) e00072120
- 16 Peplies J, Jiménez-Pavón D, Savva SC, Buck C, Günther K, Fraterman A. et al; IDEFICS consortium. Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in pre-pubertal normal weight European children from the IDEFICS cohort. Int J Obes (Lond) 2014; 38 (Suppl. 02) S39-S47
- 17 Tillotson CV, Bowden SA, Shah M, Boktor SW. Pediatric Type 2 Diabetes. [Updated 2023 Nov 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431046//
- 18 Carpenter JR, Kenward MG, White IR. Sensitivity analysis after multiple imputation under missing at random: a weighting approach. Stat Methods Med Res 2007; 16 (03) 259-275
- 19 Resche-Rigon M, White IR, Bartlett JW, Peters SA, Thompson SG. PROG-IMT Study Group. Multiple imputation for handling systematically missing confounders in meta-analysis of individual participant data. Stat Med 2013; 32 (28) 4890-4905
- 20 In Lee K, Koval JJ. Determination of the Best Significance Level in Forward Stepwise Logistic Regression. Commun Stat Simul Comput 1997; 26: 559-575
- 21 Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. Hoboken, NJ: John Wiley & Sons; 2013.
- 22 Partenope C, Pozzobon G, Weber G, Arya VB, Carceller F, Albanese A. Endocrine manifestations of paediatric intracranial germ cell tumours: from diagnosis to long-term follow-up. Endocrine 2022; 77 (03) 546-555
- 23 Jorsal T, Rørth M. Intracranial germ cell tumours. A review with special reference to endocrine manifestations. Acta Oncol 2012; 51 (01) 3-9
- 24 Takami H, Graffeo CS, Perry A, Giannini C, Daniels DJ. Epidemiology, natural history, and optimal management of neurohypophyseal germ cell tumors. J Neurosurg 2020; 134 (02) 437-445 Epub ahead of print
- 25 Chang HY, Chiu CF, Jung SM, Wong AM, Wu CT, Lo FS. Neurological and endocrinological manifestations of 49 children with intracranial pure germinoma at initial diagnosis in Taiwan. Pediatr Neonatol 2021; 62 (01) 106-112
- 26 Kurucu N, Akyüz C, Varan A, Zorlu F, Aydin B, Söylemezoglu F. et al. Primary intracranial germ cell tumors in children 36-year experience of a single center. J Cancer Res Ther 2020; 16 (06) 1459-1465
- 27 Ogawa K, Shikama N, Toita T, Nakamura K, Uno T, Onishi H. et al. Long-term results of radiotherapy for intracranial germinoma: a multi-institutional retrospective review of 126 patients. Int J Radiat Oncol Biol Phys 2004; 58 (03) 705-713
- 28 Wang S, Zhang Y, Zhou X, Zhang K, Zhang Y, Yao Y. et al. High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors. Pituitary 2022; 25 (06) 938-947
- 29 Lone DW, Sadak KT, Miller BS, Sample JM, Hubbard AK, Wolter C. et al. Growth Hormone Deficiency in Childhood Intracranial Germ Cell Tumor Survivors. J Endocrinol Metab 2022; 12 (03) 79-88
- 30 García EG, Gila ALG, Merchante E, Garvia MR, Moreno EV, Moreno AS, Vega CM. Endocrine manifestations of central nervous system germ cell tumors in children. Endocrinol Diabetes Nutr (Engl Ed). 2020; 67 (08) 540-544
- 31 Odagiri K, Omura M, Hata M, Aida N, Niwa T, Ogino I. et al. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy. Int J Radiat Oncol Biol Phys 2012; 84 (03) 632-638
- 32 Al-Chalabi M, Bass AN, Alsalman I. Physiology, Prolactin. [Updated 2023 Jul 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507829/
- 33 Sawamura Y, Ikeda J, Shirato H, Tada M, Abe H. Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer 1998; 34 (01) 104-110
- 34 Takami H, Graffeo CS, Perry A, Giannini C, Daniels DJ. Epidemiology, natural history, and optimal management of neurohypophyseal germ cell tumors. J Neurosurg 2020; 134 (02) 437-445
